Novocure Enrolls First Patient in Phase 3 Pivotal Brain Metastases Trial
October 12, 2016 07:00 ET
|
Novocure, Ltd.
ST. HELIER, N.J., Oct. 12, 2016 (GLOBE NEWSWIRE) -- Novocure (NASDAQ:NVCR) announced today that the first patient has been enrolled in the METIS trial, a phase 3 pivotal trial studying...
CORRECTING and REPLACING – Novocure to Report Third Quarter 2016 Financial Results
September 30, 2016 12:39 ET
|
Novocure, Ltd.
ST. HELIER, Jersey, Sept. 30, 2016 (GLOBE NEWSWIRE) -- In a press release issued under the same headline earlier today by Novocure, Ltd. (Nasdaq:NVCR), please note that the first paragraph...
Novocure to Report Third Quarter 2016 Financial Results
September 30, 2016 07:30 ET
|
NovoCure, Ltd.
ST. HELIER, Jersey, Sept. 30, 2016 (GLOBE NEWSWIRE) -- Novocure (NASDAQ:NVCR) announced today that it will report financial results for the third quarter 2016 on Wednesday, Nov. 2, 2016, before...